Please login to the form below

Memorial Sloan Kettering

This page shows the latest Memorial Sloan Kettering news and features for those working in and with pharma, biotech and healthcare.

AZ’s Sean Bohen to exit after business overhaul; report

Last week’s business reshuffle also saw Memorial Sloan Kettering Cancer Center physician José Baselga brought in to head the company’s cancer R&D unit – a somewhat controversial choice given

Latest news

AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief

Dr José Baselga. Dr Baselga – formerly chief medical officer at Memorial Sloan Kettering Cancer Centre – becoming head of cancer R&D.
BCMA in the spotlight as ASH abstracts drop

Biotech, Poseida Therapeutics, CARsgen Therapeutics and Memorial Sloan Kettering Cancer Centre showing impressive efficacy results in multiple myeloma.
Armoured CAR ‘could overwhelm solid tumour resistance’

Eureka Therapeutics and Memorial Sloan Kettering approach shows promise. A souped-up version of chimeric antigen receptor (CAR) T-cell therapy has shown it can improve the targeting of solid tumours. ... Eureka and Memorial Sloan Kettering have been
US insurers can peg access to ICER value reviews

Earlier this week, US industry body the Pharmaceutical Research and Manufacturers of America (PhRMA) highlighted a study by Memorial Sloan Kettering Cancer Center researchers in a blog post, which “reinforces that
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

For OSE, the deal gives it another partnership with a large pharma partner, adding to collaborations with Memorial Sloan Kettering Cancer Centre in the US and biotech Selexis on immuno-oncology,

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

No other financial details were disclosed. Fate Therapeutics entered a three year arrangement with Memorial Sloan Kettering Cancer Center to use engineered pluripotent cell lines to develop T cell product candidates.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Lilly appoints Maura Dickler as VP of late phase oncology development

She will join the pharma firm from the Memorial Sloan Kettering Cancer Center. ... She will move to the pharmaceutical company from the prestigious Memorial Sloan Kettering Cancer Center, where she currently serves as associate member, Breast Medicine
José Baselga joins BMS’ board of directors

Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and
OncoMed’s CMO steps down

Prior to this, Dr Dupont was director of early and late stage development at Genentech, and served as a researcher in tumour immunology at the Memorial Sloan Kettering Cancer Center.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Getting personal with wearable tech

In July 2016, a prestigious US cancer centre, The Memorial Sloan Kettering Cancer Center (MSK), announced their plans to evaluate wearables and other mobile technology to assess cancer patients' quality of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Up to £50, 000 with Benefits

Senior Medical Writer: Salary TBC

Project Manager/ Account Manager: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Digital Account Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The importance of co-creation with patients: Overcoming the barriers...
Three billboards on the road to multichannel: Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....